Skip to main content
SpringerLink
Log in

Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes’ Fertility

  • Chapter
  • First Online:
Exercise and Human Reproduction

Abstract

Evidence suggests that many athletes use anabolic-androgenic steroids (AAS), especially those who practice strength modalities. In recent years, regrettably, the use of AAS has spread among many women athletes. Besides being a prohibited practice, the use of AAS can influence negatively the health of these athletes. Among these numerous negative effects, evidence supports the abuse of steroids can adversely affect the fertility and reproductive organs of women severely.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Büttner A, Thieme D. Side effects of anabolic androgenic steroids: pathological findings and structure–activity relationships. In: Thieme D, Hemmersbach P, editors. Doping in sports: biochemical principles, effects and analysis. Berlin: Springer; 2010. p. 459–84.

    Google Scholar 

  2. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004;34(8):513–54.

    Article  PubMed  Google Scholar 

  3. Sjöqvist F, Garle M, Rane A. Use of doping agents, particularly anabolic steroids, in sports and society. Lancet. 2008;371(9627):1872–82.

    Article  PubMed  Google Scholar 

  4. Christakopoulos A, Ericsson M, Garle M, Villén T, Beck O. Anabolic androgenic steroids are more common in society than in sports. Lakartidningen. 2013;110(39–40):1732–4.

    PubMed  Google Scholar 

  5. Abrahin OSC, de Sousa EC, Santos AM. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review. Subst Use misuse. 2014;49(9):1156–62.

    Article  PubMed  Google Scholar 

  6. Stubbe JH, Chorus AM, Frank LE, Hon O, Heijden PG. Prevalence of use of performance enhancing drugs by fitness centre members. Drug Test Anal. 2014;6(5):434–8.

    CAS  PubMed  Google Scholar 

  7. Strauss RH, Liggett MT, Lanese RR. Anabolic steroid use and perceived effects in ten weight-trained women athletes. J Am Med Assoc. 1985;253(19):2871–3.

    Article  CAS  Google Scholar 

  8. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270(10):1217–21.

    Article  CAS  PubMed  Google Scholar 

  9. Pereira HMG, Sardela VF. Stimulant doping agents used in Brazil: prevalence, detectability, analytical implications, and challenges. Subst Use Misuse. 2014;49(9):1098–114.

    Article  PubMed  Google Scholar 

  10. Thorlindsson T, Halldorsson V. Sport, and use of anabolic androgenic steroids among Icelandic high school students: a critical test of three perspectives. Subst Abuse Treat Prev Policy. 2010;5:32.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Dunn M, White V. The epidemiology of anabolic–androgenic steroid use among Australian secondary school students. J Sci Med Sport. 2011;14(1):10–4.

    Article  PubMed  Google Scholar 

  12. Johnston L, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2011. Volume I: secondary school students. Ann Arbor: Institute for Social Research, The University of Michigan; 2012.

    Google Scholar 

  13. Pärssinen M, Kujala U, Vartiainen E, Sarna S, Seppala T. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000;21(3):225–7.

    Article  PubMed  Google Scholar 

  14. Petersson A, Garle M, Granath F, Thiblin I. Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care: a controlled retrospective cohort study. Drug Alcohol Depend. 2006;81(3):215–20.

    Article  CAS  PubMed  Google Scholar 

  15. Santora LJ, Marin J, Vangrow J, Minegar C, Robinson M, Mora J, Frieds G. Coronary calcification in body builders using anabolic steroids. Prev Card. 2006;9(4):198–201.

    Article  Google Scholar 

  16. Paolo M D, Agozzino M, Toni C, Luciani AB, Molendini L, Scaglione M, Arbustini E. Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol. 2007;114(1):114–7.

    Article  PubMed  Google Scholar 

  17. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids. Sports Med. 1995;19(5):326–40.

    Article  CAS  PubMed  Google Scholar 

  18. Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxic Lett. 2005;158(3):167–75.

    Article  CAS  Google Scholar 

  19. Melnik B, Jansen T, Grabbe S. Abuse of anabolic‐androgenic steroids and bodybuilding acne: an underestimated health problem. J Deut Dermat Gesell. 2007;5(2):110–7.

    Article  Google Scholar 

  20. Casavant MJ, Blake K, Griffith J, Yates A, Copley LM. Consequences of use of anabolic androgenic steroids. Ped Clin N Am. 2007;54(4):677–90.

    Article  Google Scholar 

  21. Wu FCW. Endocrine aspects of anabolic steroids. Clin Chem. 1997;43(7):1289–92.

    CAS  PubMed  Google Scholar 

  22. Clark AS, Costine BA, Jones BL, Kelton-Rehkopf MC, Meerts SH, Nutbrown-Greene LL, Henderson LP. Sex-and age-specific effects of anabolic androgenic steroids on reproductive behaviors and on GABAergic transmission in neuroendocrine control regions. Brain Res. 2006;1126(1):122–38.

    Article  CAS  PubMed  Google Scholar 

  23. Elliot DL, Goldberg L. Women and anabolic steroids. Anab Steroids Sport Exerc. 2000;2:225–46.

    Google Scholar 

  24. Burger HG. Androgen production in women. Fertil Steril. 2002;77(4):3–5.

    Article  Google Scholar 

  25. Basaria S, Wahlstrom JT, Dobs AS. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001;86(11):5108–17.

    Article  CAS  PubMed  Google Scholar 

  26. Burger HG. Androgen production in women. Fertil Steril. 2002;77(4):3–5.

    Article  Google Scholar 

  27. Judd HL, Lucas WE, Yen SS. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obs Gynecol. 1974;118(6):793–8.

    Article  CAS  Google Scholar 

  28. Obasanjo IO, Cline JM, Schmotzer S, Weaver DS. Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques. Menopause. 1998;5(3):163–8.

    CAS  PubMed  Google Scholar 

  29. Sprando RL, Collins TF, Black TN, Olejnik N, Grundel E, Ruggles DI. Effects of androstenedione on in utero development in rats. Food Chem Toxicol. 2004;42(6):917–24.

    Article  CAS  PubMed  Google Scholar 

  30. Rubiera-Gerez JR, Frei F, Camargo IC. Histological assessment of ovaries and uterus of rats subjected to nandrolone decanoate treatment. Contraception. 2005;72:77–80.

    Article  Google Scholar 

  31. Cherici-Camargo IC, Barreiros-De Souza R, Mesquita S, Chuffa LG, Frei F. Ovarian histology and follicular score in female rats treated with nandrolone decanoate and submitted to physical effort. Acta Biol Hung. 2009;60(3):253–61.

    Article  PubMed  Google Scholar 

  32. Cherici-Camargo IC, Gaspar ALC, Frei F, Mesquita SD. Effects of androgenic anabolic steroids on the uterus and reproductive parameters of adult female rats. Rev Bras Ginecol Obs. 2009;31(9):453–60.

    Article  Google Scholar 

  33. De Almeida-Chuffa LG, de Souza RB, Frei F, Mesquita S, Cherici-Camargo IC. Nandrolone decanoate and physical effort: histological and morphometrical assessment in adult rat uterus. Anatom Record. 2011;294(2):335–41.

    Article  Google Scholar 

  34. Karbalay-Doust S, Noorafshan A, Ardekani FM, Mirkhani H. The reversibility of sperm quality after discontinuing nandrolonendecanoate in adult male rats. Asian J Androl. 2007;9:235–9.

    Article  CAS  PubMed  Google Scholar 

  35. Bordbar H, Mesbah F, Talaei T, Dehghani F, Mirkhani H. Modulatory effect of gonadotropins on rats’ ovaries after nandrolone decanoate administration: a stereological study. Iran J Med Sci. 2014;39(1):44–50.

    PubMed  PubMed Central  Google Scholar 

  36. Howe GR, Morello CJ. Effects of an anabolic steroid on reproduction in female rats. Steroid. 1985;45(6):495–501.

    Article  Google Scholar 

  37. Bronson FH, Nguyen KQ, Delarosa J. Effect of anabolic steroid on physiological characteristics of female mice. Physiol Behav. 1996;59:49–55.

    Article  CAS  PubMed  Google Scholar 

  38. Korkia P, Stimson GV. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med. 1997;18(7):557–62.

    Article  CAS  PubMed  Google Scholar 

  39. Blasberg ME, Langan CJ, Clark AS. The effects of alphathyltestosterone, methandrostenolone and nandrolone decanoate on the rat estrous cycle. Physiol Behav. 1997;61:265–72.

    Article  CAS  PubMed  Google Scholar 

  40. Graham S, Kennedy M. Recent developments in the toxicology of anabolic steroids. Drug safety. 1990;5(6):458–76.

    Article  CAS  PubMed  Google Scholar 

  41. Kao LW, Weisz J. Direct effect of testosterone and its 5alpha-reduced metabolites on pituitary LH and FSH release in vitro: change in pituitary responsiveness to hypothalamic extract. Endocrinology. 1975;96(2):253–60.

    Article  CAS  PubMed  Google Scholar 

  42. Strauss JF, Martinez F, Kiriakidou M. Placental steroid hormone synthesis: unique features and unanswered questions. Biol Reprod. 1996;54(2):303–11.

    Article  CAS  PubMed  Google Scholar 

  43. Penatti CA, Oberlander JG, Davis MC, Porter DM, Henderson LP. Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse. Neuropharmacology. 2011;61(4):653–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Friedl KE, Yesalis CE. Self-Treatment of Gynecomastia in Bodybuilders Who Use Anabolic Steroids. Case Reports. Phys Sportsmed. 1989;17(3):67–71.

    Article  CAS  PubMed  Google Scholar 

  45. Ruiz-Cortés ZT. Gonadal sex steroids: production, action and interactions in mammals. In: Ostojic SM, editor. Steroids—from physiology to clinical medicine. Rijeka: Intech; 2012. doi:10.5772/46119.

    Google Scholar 

  46. Anderson E. In vivo and in vitro effects of androgens on rat ovarian granulosa cells. Am J Obstet Gynecol. 1989;160(4):782–8.

    Article  CAS  PubMed  Google Scholar 

  47. Anderson E, Little B, Lee GS. Androgen-induced changes in rat ovarian granulosa cells in vitro. Tiss Cell. 1987;19(2):217–34.

    Article  CAS  Google Scholar 

  48. Mobini-Far HR, Ågren G, Lindqvist AS, Marmendal M, Fahlke C, Thiblin I. Administration of the anabolic androgenic steroid nandrolone decanoate to female rats causes alterations in the morphology of their uterus and a reduction in reproductive capacity. Eur J Obs Gynec Repr Biol. 2007;131(2):189–97.

    Article  CAS  Google Scholar 

  49. Karbalay-Doust S, Noorafshan A. Stereological estimation of ovarian oocyte volume, surface area and number: application on mice treated with nandrolone decanoate. Folia Histochem et Cytobiol. 2012;50(2):275–9.

    Google Scholar 

  50. Bassindale T, Cowan DA, Dale S, Hutt AJ, Leeds AR, Wheeler MJ, Kicmna AT. Effects of oral administration of androstenedione on plasma androgens in young women using hormonal contraception. J Clin Endoc Met. 2004;89:6030–8.

    Article  CAS  Google Scholar 

  51. Triemstra JL, Wood RI. Testosterone self-administration in female hamsters. Behav Brain Res. 2004;154(1):221–9.

    Google Scholar 

  52. Bento-Silva MT, Martins MDCDC, Torres-Leal FL, Barros TL, Carvalho ILDNF, Carvalho Filho HA, Almeida FRDC. Effects of administering testosterone undecanoate in rats subjected to physical exercise: effects on the estrous cycle, motor behavior and morphology of the liver and kidney. Braz J Pharm Sci. 1985;46(1):79–89.

    Google Scholar 

  53. Kicman AT. Pharmacology of anabolic steroids. BJ Pharm. 2008;154(3):502–21.

    Google Scholar 

  54. Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 2006;5(2):182–93.

    Google Scholar 

  55. Clark AS, Blasberg ME, Brandling-Bennett EM. Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle. Physiol Behav. 1998;63(2):287–95.

    Google Scholar 

  56. Malarkey WB, Strauss RH, Leizman DJ, Liggett M, Demers LM. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obs Gynec. 1991;165(5):1385–90.

    Google Scholar 

  57. Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German democratic republic government. Clin Chem. 1997;43(7):1262–79.

    Google Scholar 

  58. Ungerleider S. Faust’s gold: inside the East German doping machine. New York: Macmillan; 2001.

    Google Scholar 

  59. Spitzer G. Ranking number 3 in the world: how the addiction to doping changed sport in the GDR. In: Spitzer G, editor. Doping and doping control in Europe. Aachen: Meyer & Meyer Sport; 2006. p. 57–77.

    Google Scholar 

  60. Prendergast HM, Bannen T, Erickson TB, Honore KR. The toxic torch of the modern olympic games. Veter Hum Toxic. 2003;45(2):97–102.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Education, Universidad de Las Palmas de GranCanaria, C/ Consuela la Maestra 29, C Santa María de Guía, 35017, Islas Canarias, Spain

    Juan Manuel García-Manso BS, MS, PhD

  2. Laboratorio de Investigación de Ciencias del Deporte, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain

    Teresa Valverde Esteve PhD

Authors
  1. Juan Manuel García-Manso BS, MS, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa Valverde Esteve PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Manuel García-Manso BS, MS, PhD .

Editor information

Editors and Affiliations

  1. Department of Morphological Sciences, University of Cordoba Department of Morphological Sciences, Cordoba, Spain

    Diana Vaamonde

  2. Division of Medical Physiology, Stellenbosch University , Tygerberg, South Africa

    Stefan S du Plessis

  3. Cleveland Clinic Foundation, American Centre for Reproductive Medicin Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Ashok Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

García-Manso, J., Valverde Esteve, T. (2016). Consequences of the Use of Anabolic-Androgenic Steroids on Female Athletes’ Fertility. In: Vaamonde, D., du Plessis, S., Agarwal, A. (eds) Exercise and Human Reproduction. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3402-7_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3402-7_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3400-3

  • Online ISBN: 978-1-4939-3402-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation